Trial to Evaluate the Safety, Tolerability, and Immunogenicity of A Hexavalent Group B Streptococcus Vaccine When Administered Concomitantly With Tdap in Healthy Nonpregnant Women

Condition:   Group B Streptococcus Infections Interventions:   Biological: Hexavalent Group B streptococcus vaccine;   Biological: Tetanus, diphtheria, and acellular pertussis vaccine;   Biological: Placebo Sponsor:   Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials